91 results
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
5 Jan 21
Preliminary information
4:10pm
of a majority of the shares of issued and outstanding common stock, par value $0.001 (the “Majority Shareholders”) of Organicell Regenerative Medicine, Inc … ”), and the rules and regulations prescribed thereunder and notice of the action by written consent in lieu of a meeting of the Majority Shareholders
DEF 14C
OCEL
Organicell Regenerative Medicine, Inc.
19 Jan 21
Information statement
7:11am
of a majority of the shares of issued and outstanding common stock, par value $0.001 (the “Majority Shareholders”) of Organicell Regenerative Medicine, Inc … ”), and the rules and regulations prescribed thereunder and notice of the action by written consent in lieu of a meeting of the Majority Shareholders
DEF 14C
OCEL
Organicell Regenerative Medicine, Inc.
2 Jun 20
Information statement
9:00am
of a majority of the shares of issued and outstanding common stock, par value $0.001 (the “Majority Shareholders”) of Organicell Regenerative Medicine, Inc … ”), and the rules and regulations prescribed thereunder and notice of the action by written consent in lieu of a meeting of the Majority Shareholders pursuant
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
11 Dec 23
Preliminary information
5:22pm
OF STOCKHOLDER ACTION BY WRITTEN CONSENT
Dear Stockholders:
The purpose of this letter is to inform you that on December 8, 2023, the holders of a majority … by the Company’s issued and outstanding shares of Series C Non-Convertible Preferred Stock (the “Majority Voting Stockholders”), pursuant to a written consent
PRE 14C
OCEL
Organicell Regenerative Medicine, Inc.
10 Jul 15
Preliminary information
12:00am
is being furnished to you to inform you that the foregoing action has been approved by the holder of a majority of the outstanding shares … to the stockholders. You are urged to read the Information Statement in its entirety for a description of the action taken by the majority stockholders
PRE 14C
3767yaoi
1 Aug 23
Preliminary information
4:15pm
PRE 14C
9p8jmcqb19xgdq
22 May 20
Preliminary information
4:30pm
8-K
EX-3.2
4164qao28l0nmns6
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm
S-1
EX-3.2
hhl02w29l1tk k3
4 Sep 12
IPO registration
12:00am
DEF 14C
0vcd30wi963 zb
20 Dec 23
Information statement
6:30am
DEF 14C
d6kx d6ykxszfv
14 Aug 23
Information statement
4:34pm
DEF 14C
ij2unc9w84trbun
5 Oct 21
Information statement
6:00am
PRE 14C
6bb65li6
28 Sep 23
Preliminary information
2:54pm
PRER14C
opl3lbq7h b0
30 Sep 21
Preliminary revised information
6:01am
PRER14C
cqpw54 s2sdzml
4 Oct 21
Preliminary revised information
6:02am
DEF 14C
ej2xah
29 May 18
Information statement
1:01pm
PRE 14C
trwid 16a6t
17 May 18
Preliminary information
1:18pm
8-K
EX-3.1
bzhdcryrr2 r8
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm
8-K
15zzqtx67wqs5afv6q
23 Aug 22
Entry into a Material Definitive Agreement
4:51pm